TMO BUE Week ended 24 Jul 2026

Weekly Investor Report

Name: TMO weekly investor report
Creator: Sharemaestro
License: https://sharemaestro.com/data-license/

Thermo Fisher Scientific Inc. · Healthcare · Diagnostics & Research

Open interactive chart View report data Download investor PDF

Latest close 41,200 ARS

8.1% latest week

Weekly setup

Mixed setup

The weekly trend is not active. Price is 17.1% above the Trend Line and sits at 83.9% of its 52-week range. The latest completed week returned 8.1%, after a 15.1% four-week move. The latest news-sentiment score is 54/100.

Setup score 66 out of 100

Latest Close 41,200 ARS 24 Jul 2026

1W Return 8.1% latest completed week

4W Return 15.1% short-term follow-through

12W Return 26.1% quarterly tape

Trend Breadth 44.2% 23 of 52 weeks active

Volume Ratio 2.5x vs 13-week average

What is working

Price is above the Trend Line, keeping the weekly tape constructive.
Price is above Fair Value, showing premium demand versus the model.
Activity pressure is positive on the latest completed week.
Volume is elevated versus the 13-week average, confirming attention.

What could go wrong

The trend backdrop is inactive, so price action has not confirmed a constructive regime.
Activity pressure is weak, so confirmation is not yet broad enough.
1 reversal markers appear in the recent smart-money tape.

What to watch next

Trend Line remains the key weekly regime level.
Activity pressure is the gauge to monitor for confirmation or fade.
A volume ratio above 1.5x would show stronger participation in the next move.

Price follow-through 8.1% Latest completed week; four-week move 15.1%. Indicator stack 24/100 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 56.12% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 54/100 33 relevant articles in the latest sentiment read.

01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 17.1% above the Trend Line and sits at 83.9% of its 52-week range. The latest completed week returned 8.1%, after a 15.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value

Price Trend Line Fair Value

Position in the 52-week range

Close Trend Fair

27,075 ARS 83.9% 43,920 ARS

Range location83.9%Shows where the latest close sits between the 52-week low and high.

Trend distance17.1%Price premium or discount versus the weekly Trend Line.

Fair-value gap38.1%Premium demand or model discount versus Sharemaestro Fair Value.

High-water gap-6.2%Distance from the latest 52-week high.

02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 2.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction

30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul

Up week Down week

Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.3212-week average 0.10

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.

Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.

Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.

Activity pressure0.32Current proprietary activity-pressure read.

Buy signals0Accumulation signal count in the latest 12 weeks.

Reversal markers11 reversal markers

No recent accumulation markers. 1 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 15.1% over four weeks, 26.1% over 12 weeks, and 47.1% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W8.1%

4W15.1%

12W26.1%

26W-3.9%

52W47.1%

Active trend streak0 weeks

Active weeks in one year23

Trend breadth44.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership

Pressure1.26Latest activity-pressure read.

Pressure change497.4%Four-week change in activity pressure.

Leadership-5.60Latest relative-leadership reading.

RS change59.7%Four-week change in relative leadership.

04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment54/100

Weighted news tone is neutral across 33 relevant articles.

8 positive · 23 neutral · 2 negative

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal

06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.

Options expected move-Nearest-chain priced movement where available.

52-week drawdown-6.2%Distance below the 52-week high.

13-week volatility4.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

30 Jan 27 Feb 27 Mar 24 Apr 22 May 19 Jun 24 Jul

Weeks higher13 of 2613 weeks finished lower.

Best week+10.1%Week of 29 May.

Worst week-8.8%Week of 24 Apr.

Latest week+8.1%Week of 24 Jul.

Shape of recent returns

Strong gains6

Modest gains7

Flat weeks0

Modest losses7

Sharp losses6

Recent vol4.8%13-week weekly-return volatility.

Base vol5.5%52-week weekly-return volatility.

Up/down split30/22Count of positive and negative weeks in the 52-week window.

Average skew4.4% / -3.9%Average positive week versus average negative week.

07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

SectorAR Healthcare

4-week rank1 / 20

Group average4.0%

Trend breadth45.0%

Trend45.0%active weekly trend signals

MD80.0%positive activity pressure

RS35.0%positive relative leadership

Four-week leaders

TMO · BUE15.1%ABT · BUE14.7%BMY · BUE13.3%AMGN · BUE8.7%ABBV · BUE7.3%

IndustryAR Diagnostics & Research

4-week rank1 / 1

Group average15.1%

Trend breadth0.0%

Trend0.0%active weekly trend signals

MD100.0%positive activity pressure

RS0.0%positive relative leadership

Four-week leaders

TMO · BUE15.1%

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape58/100

Trend, activity pressure, participation, and risk combine to a 58/100 tape read.

Indicator analysis23/100

Latest 12-week confirmation: trend 0/12, activity pressure 6/12, relative leadership 0/12.

Activity pressure 0.32; 1 reversal markers Next-Week ExpectancyPositive 56.12%

Next-week expectancy is positive with a 56.12% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100

No published factor snapshot is available yet.

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment54/100

Weighted news tone is neutral across 33 relevant articles.

Thermo Fisher Scientific Inc (TMO) Shares Surge 3.0% -- What GF Score of 85 Tells Investors Insiders50/100

No recent insider transaction evidence is stored.

Earnings50/100

No stored earnings event is currently attached to this ticker.

Week	Close	Return	Trend Line	Fair Value	Pressure	Leadership	Volume	Trend
24 Jul 2026	41,200 ARS	8.1%	35,173 ARS	29,837 ARS	1.26	-5.60	5.6K	Off
17 Jul 2026	38,120 ARS	2.0%	35,183 ARS	29,663 ARS	1.06	-10.37	1.8K	Off
10 Jul 2026	37,360 ARS	-1.2%	35,230 ARS	29,505 ARS	0.84	-14.28	336	Off
3 Jul 2026	37,800 ARS	5.6%	35,297 ARS	29,349 ARS	0.62	-11.16	5.0K	Off
26 Jun 2026	35,800 ARS	8.9%	35,344 ARS	29,184 ARS	0.21	-13.87	2.4K	Off
19 Jun 2026	32,880 ARS	3.2%	35,508 ARS	29,032 ARS	0.11	-24.87	12	Off
12 Jun 2026	31,860 ARS	-1.9%	35,749 ARS	28,900 ARS	-0.08	-28.58	672	Off
5 Jun 2026	32,468 ARS	-2.3%	35,997 ARS	28,775 ARS	-0.15	-20.98	438	Off
29 May 2026	33,240 ARS	10.1%	36,189 ARS	28,643 ARS	-0.28	-21.15	4.0K	Off
22 May 2026	30,180 ARS	2.0%	36,373 ARS	28,505 ARS	-0.67	-20.26	1.7K	Off
15 May 2026	29,600 ARS	-5.8%	36,724 ARS	28,385 ARS	-0.70	-17.59	4.7K	Off
8 May 2026	31,420 ARS	-3.8%	36,995 ARS	28,272 ARS	-0.80	-14.27	2.1K	Off
1 May 2026	32,660 ARS	2.4%	37,141 ARS	28,142 ARS	-0.81	-12.73	854	Off
24 Apr 2026	31,900 ARS	-8.8%	37,308 ARS	28,005 ARS	-0.87	-14.93	4.2K	Off

How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.